Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: A 2-year study

Bone

Volumn 19, Issue 4, 1996, Pages 387-394

  Gutteridge, D H ^a   Retallack, R W ^a   Ward, L C ^a   Stuckey, B G A ^a   Stewart, G O ^c   Prince, R L ^a   Kent, G N ^b   Bhagat, C I ^b   Price, R I ^a   Thompson, R I ^a   Nicholson, G C ^c,d  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

^d University Department of Medicine   (Australia)

Author keywords

IV pamidronate; Lytic XR lesions; Neutropenia; Paget's disease; Relapse; Remission

Indexed keywords

ALKALINE PHOSPHATASE; HYDROXYPROLINE; PAMIDRONIC ACID;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; BIOCHEMISTRY; BONE PAIN; BONE RADIOGRAPHY; BONE TURNOVER; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HEMATOLOGY; HUMAN; HYDROXYPROLINE URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYALGIA; NEUTROPENIA; NEUTROPHIL; PAGET BONE DISEASE; RELAPSE; REMISSION;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; BONE AND BONES; DIPHOSPHONATES; FEMALE; HUMANS; HYDROXYPROLINE; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUTROPHILS; OSTEITIS DEFORMANS; PAIN; PAIN MEASUREMENT; RECURRENCE;

EID: 0030271659     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00224-4     Document Type: Article

References (21)

1. 1. Adami, S., Salvagno, G., Guarrera, G., Montesanti, F., Garavelli, S., Rosini, S., and Lo Cascio, V. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1, 1-bisphosphonate. Calcif Tissue Int 39:226-229; 1986.
2. 2. Adamson, B. B., Gallacher, S. J., Byars, J., Ralston, S. H., Boyle, I. T., and Boyce, B. D. Mineralization defects with pamidronate therapy for Paget's disease. Lancet 342:1459-1460; 1993.
3. 3. Bijvoet, O. L. M., Frijlink, W. B., Jie, K., van der Linden, H., Meijer, C. J. L. M. et al. APD in Paget's disease of bone: role of the mononuclear phagocyte system? Arthrit Rheum 23:1193-1204; 1980.
4. 4. Cantrill, J. and Anderson, D. C. Treatment of Paget's disease of bone. Clin Endocrinol 32:507-518; 1990
5. 5. Fenton, A., Gutteridge, D. H., Kent, G. N., Price, R. I., Retallack, R. W., Bhagat, C. L., Worth, G. K., Thompson, R. I., Watson, I. G., Barry-Walsh, C., and Matz, L. R. Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses. Clin Endocrinol 34:197-204; 1991.
6. 6. Fraser, T. R. C., Ibbertson, H. K., Holdaway, I. M., Rutland, M., King, A., Dodd, G., and Wattie, D. J. Effective oral treatment of severe Paget's disease of bone with APD; a comparison with combined calcitonin and EHDP. Aust NZ J Med 14:811-818; 1984.
7. 7. Frijlink, W. B., Bijvoet, O. L. M., teVelde, J., and Heynen, G. Treatment of Paget's disease with 3-amino-1-hydroxypropylidene-1,1-biphosphonate (APD). Lancet 1:799-803; 1979.
8. 8. Gallacher, S., Boyce, B., Patel, U., Jenkins, A., Ralston, S. H., and Boyle, I. Clinical experience with pamidronate in the treatment of Paget's disease of bone. Ann Rheum Dis 50:930-933; 1991.
9. 9. Harinck. H. I. J., Bijvoet, O. L. M., Blanksma, H. J., and Dahlinghaus-Nienhuys, P. J. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin Orthop Rel Res 217:79-98; 1987.
10. 10. Harinck, H. I. J., Papapoulos, S. E., Blanksma, H. J., Moolenaar, A. J., Vermeij, P., and Bijvoet, O. L. M. Paget's disease of bone: early and late responses to three different modes of treatment with amino-hydroxypropylidene bisphosphonate (APD). BMJ 295:1301-1305; 1987.
11. 11. Maldague, B. and Malghem, J. Dynamic radiologic patterns of Paget's disease of bone. Clin Orthop 217:126-151; 1987.
12. 12. Mautalen, C. A., Casco, C. A., Gonzalez, D., Ghiringhelli, G. R., Massironi, C., Fromm, G. A., and Plantalech, L. Side effects of disodium aminohydroxypropylidene diphosphonate (APD) during treatment of bone diseases. BMJ 288:828-829; 1984.
13. 13. O'Doherty, D. P., Bickerstaff, D. R., McCloskey, E. V., Hamdy, N. A. T., Beneton, M. N. C., Harris, S., Mian, M., and Kanis, J. A. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate. J Bone Miner Res 5:483-491; 1990.
14. 14. Patel, S., Stone, M. D., Coupland, C., and Hosking, D. J. Determinants of remission of Paget's disease of bone. J Bone Miner Res 8:1467-1473; 1993.
15. 15. Price, R. I., Gutteridge, D. H., Stuckey, B. G. A., Kent, G. N., Retallack, R. W., Prince, R. L., Bhagat, C. I., Johnston, C., Nicholson, G. C. and Stewart, G. D. Rapid, divergent changes in spinal and forearm bone density following short term intravenous treatment of Paget's disease with pamidronate disodium. J Bone Miner Res 8:209-217; 1993.
16. 16. Ryan, P., Sherry, M., Gibson, T., and Fogelman, I. Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1, 1-bisphosphonate (APD). Br J Rheumatol 31:97-101; 1992.
17. 17. St. John, A., Davies, C., Riley, W. J., Kent, G. N., Brown, R. C., Aston, J. P., Weeks, I., and Woodhead, J. S. Comparison of the performance and clinical utility of a carboxy-terminal assay and an intact assay for parathyroid hormone. Clin Chem Acta 178:215-223; 1988.
18. 18. Stone, M. D., Hawthorne, A., Kerr, D., Webster, G., and Hosking, D. J. Treatment of Paget's disease with intermittent low dose infusions of disodium pamidronate. J Bone Miner Res 5:1231-1235; 1990.
19. 19. Stone, M. D., Marshall, D. H., Hosking, D. J., Perkins, A. C., Evans, A. J., and Wastie, M. L. Bisphosphonate space measurement in Paget's disease of bone treated with APD. J Bone Miner Res 7:295-301; 1992.
20. 20. Thiebaud, D., Jaeger, P., Gobelet, C., Jacquet, A. F., and Burckhardt, P. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Am J Med 85:207-212; 1988.
21. 21. Thiebaud, D., Portmann, L., and Burckbardt, P. Maladie de Paget moderée, traitée par le pamidronate; experience chez 43 patients avec une perfusion unique de 60 mg d'une duree variable de 1 a 24 heures. Schweiz Med Wochenschr 122:1889-1894; 1992.